ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

Raub Corrects Record on ALERT

April 20, 1984

NCI Programs: Report Calls for Expansion of Colorectal Cancer Research

April 28, 2000

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

October 4, 1985

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

Other DCT Concepts Approved By BSC

June 6, 1986

In Brief: Potter Resigns As director Of Lombardi Cancer Center; Search Committee To Look for Successor

July 24, 1987